Analysis of the Pharmacodynamic Material Basis and Mechanism of Dendrobium Nobile in the Treatment of Nervous System Diseases Using Integrative Network Pharmacology

DUAN Cancan; WANG Qingchun; ZHAO Zefen; CAI Qiuxue; LIU Fang; YAN Renyi; HE Tianmu; WANG Yazhi; LI Guilin; ZHANG Jianyong

doi:10.13386/j.issn1002-0306.2020110140

Volume 42 Issue 13

Jun. 2021

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2021 > 42(13): 1-10. > DOI: 10.13386/j.issn1002-0306.2020110140

DUAN Cancan, WANG Qingchun, ZHAO Zefen, et al. Analysis of the Pharmacodynamic Material Basis and Mechanism of Dendrobium Nobile in the Treatment of Nervous System Diseases Using Integrative Network Pharmacology[J]. Science and Technology of Food Industry, 2021, 42(13): 1−10. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2020110140.

Citation:

PDF (9724 KB)

Analysis of the Pharmacodynamic Material Basis and Mechanism of Dendrobium Nobile in the Treatment of Nervous System Diseases Using Integrative Network Pharmacology

1.
Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China
2.
School of Pharmacy, Zunyi Medical University, Zunyi 563009, China
3.
Double-Crane Pharmaceutical Co., Ltd.(Hainan), Haikou 570311, China
4.
Yunnan Dehong Institute of Tropical Agricultural Sciences, Ruili 678600, China

More Information

Received Date: November 16, 2020
Available Online: May 10, 2021

Graphical Abstract

Abstract

Abstract

Objective: To analyze the pharmacodynamic material basis and mechanism of Dendrobium nobile in the treatment of nervous system diseases using integrative network pharmacology. Methods: The chemical constituents of Dendrobium nobile were collected from the databases of Si-noMed, China HowNet and Wanfang. The constituents were input into TargetNet database for potential target capture. The obtained target was then imported into CTD database to get related diseases. The gene function and pathway enrichment of the target were analyzed by DAVID database. Component-target network and target-disease network were constructed by Cytoscape software. The relation between the ingredients and targets were validated by AutoDock Vina software. Results: A total of 47 components were collected from Dendrobium nobile, which could act on 88 targets. Nobilin D, Nobliomethylene, decumbic acid B, (+)-dendrolactone, (−)-denobilone A, Nobilin were the main material basis for the treatment of nervous system diseases through multivariate network analysis. The components in Dendrobium nobile mainly acted on these key targets including MIF, ERS2, CYP19A1, ABCG2, TLR9 and DRD5, and further regulate the Sphingolipid signaling pathway, Cocaine addiction and Serotonergic synapse for treating nervous system diseases. Conclusion: This study reveals the multi-component, multi-target and multi-pathway action of Dendrobium nobile, and provides a new basis for further research on the mechanism of Dendrobium nobile in the treatment of nervous system diseases.
- Dendrobium nobile,
- nervous system diseases,
- network pharmacology,
- mechanism

FullText(HTML)

References (37)

References

[1]	刘宏帅, 石海莲, 高雅婵, 等. 神经炎症与神经退行性疾病的关系及中药调控作用研究进展[J]. 上海中医药大学学报,2016,30(5):82−89.
[2]	王昊. 基于网络药理学的开心散防治阿尔茨海默病的分子机制研究[D]. 咸阳: 陕西中医药大学, 2018.
[3]	孙树森, 韩容, 赵志刚. 2016年上半年美国FDA批准的新分子实体与评价: 神经系统疾病、呼吸系统疾病、皮肤病治疗用药和造影剂[J]. 药品评价,2017,14(4):12−17. doi: 10.3969/j.issn.1672-2809.2017.04.002
[4]	许莉, 王江瑞, 郭力, 等. 金钗石斛化学成分的研究[J]. 中成药,2018,40(5):108−110.
[5]	周威, 夏杰, 孙文博, 等. 金钗石斛的化学成分和药理作用研究现状[J]. 中国新药杂志,2017,26(22):2693−2700.
[6]	姜宁, 范琳犀, 杨玉洁, 等. 金钗石斛提取物对慢性不可预见应激模型小鼠的抗抑郁作用[J]. 生理学报,2017,69(2):159−166.
[7]	Yan Y, Wang C. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity[J]. Journal of Molecular Biology,2006,364(5):853−862. doi: 10.1016/j.jmb.2006.09.046
[8]	石京山, 王茜, 李利生, 等. 金钗石斛生物碱抗老年痴呆基础研究[J]. 神经药理学报,2017,7(2):6. doi: 10.3969/j.issn.2095-1396.2017.02.006
[9]	Sharma A A, Jen R, Kan B, et al. Impaired NLRP3 inflammasome activity during fetal development regulates IL-1β production in human monocytes[J]. European Journal of Immunology,2015,45(1):238−249. doi: 10.1002/eji.201444707
[10]	Yang S, Gong Q, Wu Q, et al. Alkaloids enriched extract from Dendrobium nobile Lindl. attenuates tau protein hyperphosphorylation and apoptosis induced by lipopolysaccharide in rat brain[J]. Phytomedicine,2014,21(5):712−716. doi: 10.1016/j.phymed.2013.10.026
[11]	林牧, 龚其海, 吴芹, 等. 金钗石斛多糖对脂多糖作用大鼠皮层胶质细胞-神经元体系的保护作用[J]. 中国药理学通报,2016,32(8):1144−1148. doi: 10.3969/j.issn.1001-1978.2016.08.022
[12]	席乐迎, 任献青, 许爽, 等. 基于网络药理学的中药作用机制研究进展[J]. 现代中西医结合杂志,2020,29(29):3287−3290, 3296. doi: 10.3969/j.issn.1008-8849.2020.29.023
[13]	Huang L P, Yan B, Hou M, et al. Study on material basis and mechanism of erzhi wan prevent Alzheimer's disease by network pharmacology[J]. China Journal of Chinese Materiamedica,2017,42(21):4211−4217.
[14]	杜梨, 袁斌, 张百霞, 等. 基于“中药作用机理辅助解析系统”的大黄抗高血脂作用机制研究[J]. 中国中药杂志,2015,40(19):3703−3708.
[15]	童黄锦, 石芸, 吉敬, 等. 白鲜皮挥发油中潜在活性成分的网络药理学研究[J]. 中国中药杂志,2020,45(5):1135−1141.
[16]	吴青华, 李冰涛, 朱水兰, 等. 蒙古族药芯芭治疗2型糖尿病的网络药理学研究[J]. 中国中药杂志,2020,45(8):1764−1771.
[17]	顾观光. 神农本草经[M]. 北京: 学苑出版社, 2007.
[18]	包雪声, 顺庆生, 张申洪, 等. 中国药用石斛图志[M]. 上海: 上海科学技术文献出版社, 2005: 34.
[19]	李艳萍, 李海燕, 纪晓婉, 等. 金钗石斛叶中总黄酮的提取分离及体外抗阿尔茨海默病活性研究[J]. 中国药房,2018,29(3):330−333. doi: 10.6039/j.issn.1001-0408.2018.03.10
[20]	姜琳珊, 李菲, 聂晶, 等. 金钗石斛总生物碱对APP/PS1转基因小鼠学习记忆能力的影响[J]. 遵义医学院学报,2016,39(3):246−249.
[21]	Huitron-Resendiz S, Henriksen S J, Barr M C, et al. Methamphetamine and lentivirus interactions: Reciprocal enhancement of central nervous system disease[J]. Journal of Neurovirology,2010,16(4):268−278. doi: 10.3109/13550284.2010.497807
[22]	Cox G M. Macrophage migration inhibitory factor: A study of the effects on the central nervous system microenvironment in experimental autoimmune encephalomyelitis[J]. Dissertations & Theses-Gradworks,2011:3496009.
[23]	Zhijie H, Jiaojiao Q, Jiehong Z, et al. Genetic variant rs755622 regulates expression of the multiple sclerosis severity modifier d-dopachrometautomerase in a sex-specific way[J]. BioMed Research International,2018,20(18):1−7.
[24]	Chen L H, Fan Y H, Kao P Y P, et al. Genetic polymorphisms in estrogen metabolic pathway associated with risks of Alzheimer's disease: Evidence from a southern chinese population[J]. Journal of the American Geriatrics Society,2017,65(2):332−339. doi: 10.1111/jgs.14537
[25]	Mao Q, Rosenberg M F, Bikadi Z, et al. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2)[J]. Current Drug Metabolism,2010,11(7):603−617. doi: 10.2174/138920010792927325
[26]	Evangelista M G, Castro S B R D, Caio César De Souza Alves, et al. Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin[J]. Autoimmunity,2016,49(4):258−267. doi: 10.3109/08916934.2016.1141898
[27]	Carolina P, Michela G, González Hugo, et al. Dopaminergic stimulation of myeloid antigen-presenting cells attenuates signal transducer and activator of transcription 3-activation favouring the development of experimental autoimmune encephalomyelitis[J]. Frontiers in Immunology,2018,21(9):571−587.
[28]	Levran O, Randesi M, da Rosa JC, et al. Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americanss[J]. Annals of Human Genetic,2015,79(3):188−198. doi: 10.1111/ahg.12104
[29]	Kimishima A, Wenthur C J, Eubanks L M, et al. Cocaine vaccine development: Evaluation of carrier and adjuvant combinations that activate multiple toll-like receptors[J]. Molecular Pharmaceutics,2016,13(11):3884−3890. doi: 10.1021/acs.molpharmaceut.6b00682
[30]	Miller D S, Cannon R E. Signaling pathways that regulate basal ABC transporter activity at the blood- brain barrier[J]. Current Pharmaceutical Design,2014,20(10):1463−1471. doi: 10.2174/13816128113199990457
[31]	崔莹. 老年期情感障碍患者血清细胞因子、皮质醇、认知功能及药物干预的影响[D]. 济南: 山东大学, 2011.
[32]	黄强, 汪亚楠, 韩飞, 等. 基于网络药理学的桂枝甘草汤抗失眠作用的潜在机制研究[J]. 湖南中医药大学学报,2020,40(4):452−459. doi: 10.3969/j.issn.1674-070X.2020.04.013
[33]	Mohammed S, Vineetha N S, James S, et al. Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity[J]. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology,2020,34(3):4329−4347. doi: 10.1096/fj.201902847R
[34]	He X, Huang Y, Li B, et al. Deregulation of sphingolipid metabolism in Alzheimer’s disease[J]. Neurobiology of Aging,2008,31(3):398−408.
[35]	Angelucci F, Ricci V, Pomponi M, et al. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor[J]. Journal of Psychopharmacology,2007,21(8):820−825. doi: 10.1177/0269881107078491
[36]	Wescott S A, Rauthan M, Xu X Z S. When a TRP goes bad: Transient receptor potential channels in addiction[J]. Life Sciences,2013,92(8-9):410−414. doi: 10.1016/j.lfs.2012.07.008
[37]	Jankowska A, Wesołowska A, Pawłowski M, et al. Multi-target-directed ligands affecting serotonergic neurotransmission for Alzheimer’s disease therapy: Advances in chemical and biological research[J]. Current Medicinal Chemistry,2018,24(17):2045−2067.